Form 4 for MRNA Moderna
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-08 · accession 0001127602-23-004449 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-10 | 2023-02-08+ | MRNA | Bancel Stephane | CEO, Dir | S - Sale+OE | $165.79 | -80.0K | 5.41M | -1% | -$13.26M |
| DM | 2023-02-10 | 2023-02-08+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.99 | +80.0K | 5.45M | +1% | +$79.2K |
| DM | 2023-02-10 | 2023-02-08+ | MRNA | Bancel Stephane | CEO, Dir | M - OptEx | $0.00 | -80.0K | 1.55M | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | S | D | 11,272 | $165.93 | 5,416,046 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.67 to $166.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2023-02-09 | S | D | 1,600 | $166.86 | 5,414,446 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.68 to $167.32. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2023-02-09 | S | D | 24,628 | $165.04 | 5,427,318 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.62 to $165.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2023-02-09 | S | D | 400 | $169.01 | 5,411,946 | D | — | — | (F12) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.89 to $169.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2023-02-09 | S | D | 2,100 | $168.26 | 5,412,346 | D | — | — | (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.73 to $168.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Common | Common Stock | 2023-02-09 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 7 | Common | Common Stock | 2023-02-08 | M | A | 40,000 | $0.99 | 5,451,946 | D | — | — | |
| 8 | Common | Common Stock | 2023-02-08 | S | D | 9,589 | $164.65 | 5,442,357 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.18 to $165.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 9 | Common | Common Stock | 2023-02-08 | S | D | 19,648 | $165.77 | 5,422,709 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.22 to $166.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 10 | Common | Common Stock | 2023-02-08 | S | D | 4,543 | $166.51 | 5,418,166 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.23 to $167.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 11 | Common | Common Stock | 2023-02-08 | S | D | 2,772 | $168.01 | 5,415,394 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.26 to $168.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 12 | Common | Common Stock | 2023-02-08 | S | D | 2,848 | $168.64 | 5,412,546 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.30 to $169.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 13 | Common | Common Stock | 2023-02-08 | S | D | 600 | $169.40 | 5,411,946 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $169.35 to $169.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 14 | Derivative | Stock Option (Right to Buy) | 2023-02-08 | M | D | 40,000 | $0.00 | 1,587,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F15) This option is fully vested and exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2023-02-09 | M | D | 40,000 | $0.00 | 1,547,155 | D | $0.99 · — to 2023-08-19 | 40,000 Common Stock | (F15) This option is fully vested and exercisable. |